MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Spectrum Pharmaceuticals Company Profile (NASDAQ:SPPI)

Consensus Ratings for Spectrum Pharmaceuticals (NASDAQ:SPPI) (?)
Ratings Breakdown: 2 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $8.80 (36.01% upside)

Analysts' Ratings History for Spectrum Pharmaceuticals (NASDAQ:SPPI)
Show:
DateFirmActionRatingPrice TargetActions
5/9/2016Jefferies GroupReiterated RatingHold$5.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016FBR & Co.Reiterated RatingOutperform$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2015RBC CapitalLower Price TargetOutperform$13.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2015Roth CapitalReiterated RatingNeutral$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2014R. F. LaffertyBoost Price TargetSell -> Neutral$7.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for Spectrum Pharmaceuticals (NASDAQ:SPPI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/5/2016Q1($0.32)($0.14)$28.83 million$43.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q415($0.18)($0.06)$33.87 million$50.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315($0.25)($0.28)$31.87 million$28.46 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.22)($0.01)$34.48 million$44.98 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.06)($0.07)$48.00 million$38.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2015Q414($0.16)$0.09$48.50 million$51.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314($0.17)$0.08$45.00 million$47.99 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.09)$0.09$41.50 million$46.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q114($0.22)$0.01$39.49 million$40.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2014Q313($0.11)$0.05$41.96 million$41.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q3($0.07)($0.13)$38.70 million$42.44 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q2 2013($0.12)($0.08)$33.41 million$33.23 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q1 2013($0.32)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312$0.29$0.42$68.56 million$69.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Spectrum Pharmaceuticals (NASDAQ:SPPI)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164($0.36)($0.21)($0.28)
Q2 20164($0.39)($0.24)($0.32)
Q3 20164($0.49)($0.24)($0.36)
Q4 20164($0.44)($0.21)($0.32)
(Data provided by Zacks Investment Research)
Dividend History for Spectrum Pharmaceuticals (NASDAQ:SPPI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
12/11/2012special$0.1512/18/201212/20/201212/28/2012Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Spectrum Pharmaceuticals (NASDAQ:SPPI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/5/2013Anthony E Maida IIIDirectorSell5,000$12.25$61,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2012Joseph Kenneth KellerCOOBuy10,000$10.95$109,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2012Anthony E Maida IIIDirectorSell5,000$11.09$55,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2012Anthony E Maida IIIDirectorSell5,000$12.01$60,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Spectrum Pharmaceuticals (NASDAQ:SPPI)
DateHeadline
06/24/16 06:35 PMSpectrum Pharmaceuticals Incorporated (NASDAQ:SPPI) Sellers Covered 9.15% of Their Shorts - Engelwood Daily
06/22/16 06:29 PMFirst Week of February 2017 Options Trading For Spectrum Pharmaceuticals (SPPI)
06/21/16 12:14 PMETF’s with exposure to Spectrum Pharmaceuticals, Inc. : June 21, 2016 -
06/21/16 10:43 AMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Stock Momentum Hits Weakness - CML News
06/14/16 06:11 PMCan Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Surprise Analysts this Quarter? - Investor Newswire
06/10/16 09:33 AMNew Market Research Report: Spectrum Pharmaceuticals, Inc. (formerly NeoTherapeutics, Inc.)
06/09/16 05:27 AMBRIEF-Spectrum Pharmaceuticals' unit, Allos Therapeutics and Sandoz enter settlement agreement - * On June 8, 2016, co's unit , Allos Therapeutics and Sandoz Inc entered into a settlement agreement
06/07/16 06:49 PMSPECTRUM PHARMACEUTICALS INC. (NASDAQ:SPPI) Financial Condition Compared to S&P 500 - CML News
06/01/16 09:30 AMStock Review and Earnings Check on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - HNN - Stock Review and Earnings Check on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) to report quarterly EPS of $-0.26. The company's next earnings report is expected to be ...and more »
06/01/16 09:30 AMEarnings Analysis to see: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Achillion Pharmaceuticals, Inc. (NASDAQ ... - Beacon Chronicle - Earnings Analysis to see: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Achillion Pharmaceuticals, Inc. (NASDAQ ...Beacon ChronicleLast Trade: The Company closed its last session at $7.49 with the gain of 0.81%. The market capitalization of the company is $519.13 Million, with the average Volume of 854.28K. The stock currently has its 52-Week High range of $7.74 and 52-week low ...and more »
06/01/16 06:33 AMSpectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2016 Healthcare Conference on June 8th - [at noodls] - dd5489f0-e04b-43e7-90bf-3ab7ea7ddd46.pdf June 1, 2016 HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development ...
05/31/16 06:55 PMFloating Price Update: Nektar Therapeutics (NASDAQ:NKTR) , Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Street Updates - Floating Price Update: Nektar Therapeutics (NASDAQ:NKTR) , Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)Street UpdatesSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) after beginning at $7.44, closed at $7.43 by cutting down -0.13% in recent trading session. Most recent session's volume of 641.59 thousand shares lower than its average volume of 850.83 thousand shares.and more »
05/29/16 10:16 PMStock Rating Review for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - HNN - Stock Rating Review for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)HNNInvestors may choose to follow the views of professional Wall Street analysts that regularly track the company. Covering equity analysts presently have a consensus stock rating of 1.67 on shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Covering ...and more »
05/28/16 05:14 PMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) One-Year Price Target At $9.33 - Investor Newswire - Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) One-Year Price Target At $9.33Investor NewswireFirst Call has set a 52-week price target of $9.33 on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) stock after completion of its survey. For the approaching quarter, EPS estimate is set at $-0.32 and for underway fiscal at $-1.00. This estimate for ...and more »
05/25/16 08:34 AMSPECTRUM PHARMACEUTICALS INC : Other Events (form 8-K) - 05/05 SPECTRUM PHARMACEUTICALS INC: Results of Operations and Financial Condition, Fi.. 05/05 SPECTRUM PHARMACEUTICALS: Reports First Quarter 2016 Financial Results and Pipe.. 05/05 SPECTRUM PHARMACEUTICALS: Reports First Quarter 2016 Financial Results and ...
05/25/16 06:06 AMSPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events -
05/24/16 10:31 PMEarnings Review and Stock Rundown for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Wall Street Hints and News - Earnings Review and Stock Rundown for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)Wall Street Hints and NewsEarnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) to post quarterly EPS of $-0.26. The company is expected to next publish earnings on or ...and more »
05/23/16 10:13 AMActive Stocks: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Advanced Micro Devices, Inc. (NASDAQ:AMD), The ... - KC Register - Active Stocks: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Advanced Micro Devices, Inc. (NASDAQ:AMD), The ...KC RegisterSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)'s stock had its “hold” rating reiterated by equities research analysts at Jefferies Group in a note issued to investors on Monday, Analyst Ratings Network.com reports. They presently have a $6.00 target ...and more »
05/23/16 10:13 AMStock Rating Review for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Wall Street Hints and News - Stock Rating Review for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 1.67 on shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research.and more »
05/21/16 04:59 PMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Comprehensive Income At $-5.319 - RealistInvestor.com - Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Comprehensive Income At $-5.319RealistInvestor.comFor the year ended 2015-12-31, Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)comprehensive income was $-5.319 millions whereas for the quarter ended 2015-12-31, it was $-5.319 millions. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) posted ...Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Updated Broker Price TargetsShare Trading NewsSpectrum Pharmaceuticals Incorporated (NASDAQ:SPPI) Short Interest Increased By 4.84%Wall Street Hints and Newsall 7 news articles »
05/21/16 08:41 AMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Updated Broker Price Targets - Share Trading News - Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). The latest reports which are currently in issue on Friday 20th of May state 0 analysts have a rating of “strong buy”, 0 ...and more »
05/20/16 10:24 PMGlobal Spectrum PharmaceuticalsDrugs Pipeline Review H1 2016 - ‘Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Spectrum Pharmaceuticals, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under ...
05/19/16 05:23 PMBuy Calls Count For Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) At 0 - Investor Newswire - Buy Calls Count For Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) At 0Investor NewswireSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) has a total of 2 Strong Buy recommendations and 0 Strong Sell calls as of 2016-05-18. One month ago, the count of strong buy ratings were 2 and strong sell ratings were 0. The mean analyst score was 1.67.and more »
05/19/16 05:23 PMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) One-Year Price Projection At $8.666 - Investor Newswire - Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) One-Year Price Projection At $8.666Investor NewswireSell-side analysts are certain on the prospect of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) stock. As of 2016-05-18, the stock ABR stands at 1.67. This type of rating states that whenever a stock has a score of 5, investors should avoid investing in ...and more »
05/19/16 08:37 AMInvestors Focused Movers: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) , Amarin Corporation PLC (NASDAQ:AMRN) - Street Updates - Investors Focused Movers: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) , Amarin Corporation PLC (NASDAQ:AMRN)Street UpdatesOn 5/18/2016, shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) rose +1.13% in trading session and finally closed at $7.18. The company most recent volume stood at 598.46 thousand shares as compared to its average volume of 844.39 thousand ...
05/18/16 09:53 PMETF’s with exposure to Spectrum Pharmaceuticals, Inc. : May 19, 2016 -
05/18/16 09:26 AMShare Recap and Earnings Focus on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Wall Street Hints and News - Share Recap and Earnings Focus on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)Wall Street Hints and NewsAnalysts and investors are usually very focused on company earnings numbers when they are released. Company earnings are a good way to evaluate the profitability of the company. Presently, covering analysts are anticipating Spectrum Pharmaceuticals, ...and more »
05/17/16 03:10 PMSpectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/17/16 09:05 AMTrending Tickers: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE ... - KC Register - Trending Tickers: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE ...KC RegisterSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)'s stock had its “hold” rating reiterated by equities research analysts at Jefferies Group in a note issued to investors on Monday, Analyst Ratings Network.com reports. They presently have a $6.00 target ...
05/16/16 05:03 PMConsensus Rating Review for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Wall Street Hints and News - Consensus Rating Review for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)Wall Street Hints and NewsEquity research analysts currently have a consensus rating of 1.67 on shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a ...and more »
05/16/16 05:03 PMNews review of 2 biotech stocks: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Ariad Pharmaceuticals, Inc ... - Street Register - Street RegisterNews review of 2 biotech stocks: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Ariad Pharmaceuticals, Inc ...Street RegisterSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) lost 0.57% by the end of recent close at $ 7.11. The percentage change in the price over the last fifty two weeks remained 8.38%. The price range in those 52 weeks had a highest hit of $ 7.74 while lowest ...and more »
05/14/16 05:02 PMMost recent Analysts Rating report: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) , Synta Pharmaceuticals Corp ... - Street Updates - Most recent Analysts Rating report: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) , Synta Pharmaceuticals Corp ...Street UpdatesOn 5/13/2016, shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) rose +0.57% in trading session and finally closed at $7.11. The company most recent volume stood at 1.2 million shares as compared to average volume of 855.72 thousand shares.Analyst Coverage: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)Risers & FallersCan Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)'s Touch $9.50 In Coming Year?RealistInvestor.comall 6 news articles »
05/14/16 03:51 AMTwo Stocks within Traders Limelight: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) , Lipocine Inc. (NASDAQ:LPCN) - Street Updates - Two Stocks within Traders Limelight: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) , Lipocine Inc. (NASDAQ:LPCN)Street UpdatesOn 5/11/2016, Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) ended trading session lower at $7.31 with -1.88%. The company traded a volume of 658.82 thousand shares as comparison to average volume of 846.14 thousand shares. During the 52 –week ...Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Is $-0.43 Off Its 52-Week HighMarkets DailySpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI): Stock Target from AnalystsNews TribuneEarnings Report: Spectrum Pharmaceuticals (NASDAQ:SPPI)News Oracleall 4 news articles »
05/13/16 05:35 PMCan Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)'s Touch $9.50 In Coming Year? - RealistInvestor.com - Can Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)'s Touch $9.50 In Coming Year?RealistInvestor.comSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) has a 52-week price target of $9.50 based on the recommendations collected by First Call. The firm's mean EPS in the last one year was $-0.76. The analysts are now projecting earnings of $-0.32 for upcoming ...and more »
05/13/16 12:04 PMSPECTRUM PHARMACEUTICALS INC Financials -
05/12/16 05:39 PMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) One-Year Mean Price Target At $8.666 - Investor Newswire - Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) One-Year Mean Price Target At $8.666Investor NewswireSell-side analysts are confident on the future outlook of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) stock. As of 2016-05-11, the stock has an ABR of 1.67 rating, where number 5 denotes a Strong Sell and 1 Strong Buy. The ABR is reached on the basis ...and more »
05/11/16 02:22 PMIs Spectrum Pharmaceuticals Still a Buy After Surging Higher in April? - The biotech's stock gets a lift on a positive regulatory development last month.
05/10/16 10:44 PMPerformance Recap and Target Perspective on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - B.O.D.Y Confidential - Performance Recap and Target Perspective on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)B.O.D.Y ConfidentialIn the latest trading session, shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) moved +1.68%. In order to gain some further insight on stock performance, we can take a look at the stock price relative to some moving averages. After a recent check ...and more »
05/10/16 05:37 PMCheck on Analyst Ratings Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - B.O.D.Y Confidential - Check on Analyst Ratings Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)B.O.D.Y ConfidentialCovering Wall Street analysts have an average rating of 1.67 on shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). This Zacks Research number is compiled from analysts that they have taken into consideration. This consensus rating falls on a 1 to ...and more »
05/10/16 05:37 PMEarnings Expectations Overview: Spectrum Pharmaceuticals (SPPI) - News Oracle - Earnings Expectations Overview: Spectrum Pharmaceuticals (SPPI)News OracleEarnings Estimate & Revenue Estimate of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) for the Current Quarter Jun 16: For the current Quarter, 4.00 analysts have given an Average earnings estimate of $-0.23 per share.According to the Analysts, the Low ...and more »
05/09/16 05:30 PMLast Analysts Rating Review: Envision Healthcare Holdings, Inc. (NYSE:EVHC), Spectrum Pharmaceuticals, Inc ... - Street Updates - Last Analysts Rating Review: Envision Healthcare Holdings, Inc. (NYSE:EVHC), Spectrum Pharmaceuticals, Inc ...Street UpdatesSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) moved in green zone with rise of +0.75 points or +11.72% to $7.15. The company has a market worth of $470.86M.Total 3.09 million shares were exchanged in last trading session as opposed to average ...and more »
05/09/16 04:00 AMAfter Last Week What Do Analysts Think Of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Share Trading News - After Last Week What Do Analysts Think Of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)Share Trading News04/07/2014 – Spectrum Pharmaceuticals, Inc. was downgraded to “sell” by analysts at TheStreet. The share price of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) was up +11.72% during the last trading session, with a day high of 7.33. 3089666 shares ...Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Comprehensive Income At $-3.485 Millions For Quarter Closed 2016 ...RealistInvestor.comSpectrum Pharmaceuticals Incorporated (NASDAQ:SPPI) Sellers Covered 5.41% of Their ShortsFranklin Independentall 3 news articles »
05/07/16 05:00 PMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Comprehensive Income At $-3.485 Millions For Quarter Closed 2016 ... - RealistInvestor.com - Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Comprehensive Income At $-3.485 Millions For Quarter Closed 2016 ...RealistInvestor.comFor the year ended 2016-03-31, Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) comprehensive income was $-3.485 millions whereas for the quarter ended 2016-03-31, the comprehensive income was $-3.485 millions. Spectrum Pharmaceuticals, Inc.
05/06/16 10:42 PMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Yearly EPS Target At $-1.37 - RealistInvestor.com - Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Yearly EPS Target At $-1.37RealistInvestor.comAs per Thomson Reuters, b>Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) can touch $9.25 in coming 52-weeks. The mean EPS, a year earlier was $-0.76. For the coming quarter, the EPS estimate is $-0.38 while for this fiscal the set target is $-1.37.and more »
05/06/16 10:42 PMSpectrum Pharmaceuticals, Inc. (SPPI) Jumps 11.72% on May 06 - Equities.com - Spectrum Pharmaceuticals, Inc. (SPPI) Jumps 11.72% on May 06Equities.comSpectrum Pharmaceuticals, Inc. (SPPI) was among the biggest gainers on the Russell 2000 for Friday May 06 as the stock popped 11.72% to $7.15, representing a gain of $0.75 per share. Some 3.09 million shares traded hands on 14,714 trades, compared ...and more »
05/06/16 05:35 PMBRIEF-Spectrum Pharmaceuticals Q1 loss per share $0.14 - May 5 Spectrum Pharmaceuticals Inc : * Spectrum Pharmaceuticals reports first quarter 2016 financial results and pipeline update * Q1 loss per share $0.14 * Q1 revenue $43.9 million * Q1 revenue view $28.8 million -- Thomson Reuters I/B/E/S * Q1 earnings ...
05/06/16 05:35 PMSpectrum Pharmaceuticals : Pharma reports 1Q loss - HENDERSON, Nev. (AP) _ Spectrum Pharmaceuticals Inc. (SPPI) on Thursday reported a loss of $9.3 million in its first quarter. The Henderson, Nevada-based company said it had a loss of 14 cents per share. Earnings, adjusted for amortization costs and stock ...
05/06/16 04:39 PMSPECTRUM PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report -
05/06/16 12:27 PMEdited Transcript of SPPI earnings conference call or presentation 5-May-16 8:30pm GMT -
05/06/16 06:00 AMSpectrum Pharmaceuticals Highlights an Oral Presentation on Apaziquone at the 2016 Annual Meeting of the American Urological Association Education and Research Inc. (AUA) in San Diego, California, May 6-10, 2016 - [Business Wire] - Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced today presentations of clinical data for apaziquone to be presented at an oral presentation and a moderated poster session at the American Urological Association Education and Research Inc., being held in San Diego, California, ...
About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals logoSpectrum Pharmaceuticals, Inc. is a biotechnology Company. The Company is engaged in commercial and drug development operations with a focus on hematology and oncology. The Company is engaged in acquiring, developing and commercializing the pipeline of late-stage clinical and commercial drug compounds. The Company market five drugs for the treatment of cancer, which includes FUSILEV injection for patients with advanced metastatic colorectal cancer and to counteract certain effects of methotrexate therapy; ZEVALIN injection for patients with follicular non-Hodgkin's lymphoma; FOLOTYN injection for patients with relapsed or refractory peripheral T-cell lymphoma (PTCL); MARQIBO injection for patients with Philadelphia chromosome–negative acute lymphoblastic leukemia, and BELEODAQ injection for patients with relapsed or refractory PTCL.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: SPPI
  • CUSIP: 84763A10
Key Metrics:
  • Previous Close: $6.47
  • 50 Day Moving Average: $7.12
  • 200 Day Moving Average: $6.07
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $424.41M
  • Current Quarter EPS Consensus Estimate: $-1.00 EPS
Additional Links:
Spectrum Pharmaceuticals (NASDAQ:SPPI) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha